Recombinant Mouse Nucleoporin NDC1 (Tmem48)

What is Nucleoporin NDC1 (Tmem48) and what is its primary role in cellular function?

NDC1 (Nuclear Division Cycle 1), also known as TMEM48 (Transmembrane Protein 48), is a transmembrane nucleoporin containing 656 amino acids arranged in 6-7 transmembrane domains that localizes to nuclear pore complexes (NPCs) . It functions as a dynamic membrane adaptor that helps recruit and promote the self-assembly of the nuclear pore scaffold to drive post-mitotic NPC assembly . NDC1 participates in cell mitosis by serving as a component of both the nuclear pore complex and the spindle, and has been demonstrated to control nuclear pore complex density and nuclear size in yeast and early C. elegans embryo .

Methodological approach: To study NDC1's primary functions, researchers typically employ CRISPR-Cas9 gene editing to delete the ndc1 gene locus (as demonstrated in C. elegans) followed by differential interference contrast (DIC) microscopy to observe resulting nuclear phenotypes such as reduced pronuclear size .

How does the structure of mouse NDC1 protein relate to its function?

Mouse NDC1 (Tmem48) is a putative transmembrane protein with six transmembrane domains that comprises part of the nuclear pore complex . The gene encoding NDC1 in mice is called Tmem48, and its proper splicing is critical for function. When mutations occur that affect splicing, such as those deleting exon 6 of the Tmem48 transcript, the resulting protein demonstrates functional defects .

Methodologically, researchers have studied the structural requirements by:

• Using gene cloning techniques to isolate specific regions (e.g., exon 6 and flanking regions)

• Creating expression vectors (such as pET01) containing wild-type or mutant variants

• Transiently expressing these constructs in cell lines (e.g., COS7 cells)

• Analyzing the resulting transcripts via RT-PCR to assess proper splicing

What methods are commonly employed to detect and quantify NDC1 expression in tissues?

Several complementary approaches are used to study NDC1 expression:

For transcriptomic analysis, researchers often access data from public repositories such as TCGA, GTEx, and CCLE databases, allowing comparisons of NDC1 expression across multiple tissue types and disease states .

What are the most effective approaches for recombinant expression of mouse NDC1?

For recombinant expression of mouse NDC1, researchers typically:

• Clone the full-length Tmem48 cDNA or specific domains into expression vectors compatible with mammalian expression systems

• Transform or transfect the constructs into appropriate host cells (COS7 cells have been documented as effective )

• Optimize transfection conditions using reagents such as FuGENE 6

• Extract RNA or protein for downstream applications

For functional studies, expression systems should maintain the natural transmembrane topology of NDC1. When studying mutant variants, researchers often clone DNA fragments containing specific exons (such as exon 6) and their flanking regions into vectors like pET01 .

How can researchers effectively modulate NDC1 expression for functional studies?

Several approaches have been validated for modulating NDC1 expression:

• Knockdown strategies:

  • siRNA or shRNA delivery (typically via lipofection)

  • CRISPR-Cas9 mediated deletion (as employed in C. elegans studies )

  • miRNA-based regulation (e.g., miR-421 has been shown to inhibit NDC1 expression in A549 NSCLC cells )

• Overexpression approaches:

  • Transient transfection with expression vectors

  • Stable cell line generation using antibiotic selection

  • Viral transduction systems for difficult-to-transfect cells

Effectiveness can be validated using cell viability assays (MTT, CCK-8), proliferation assays (EdU labeling), and protein expression confirmation via Western blotting .

What experimental assays can assess NDC1's functional impact on cellular processes?

Based on established research protocols, the following assays effectively measure NDC1's functional effects:

• Proliferation assays:

  • MTT assay: Cells are inoculated into 96-well plates (5×10³ cells/well) and viability is measured at 24, 48, 72, and 96 hours post-treatment

  • EdU labeling: Provides visual confirmation of DNA synthesis in proliferating cells

• Migration assays:

  • Wound healing assay: Creating an artificial wound using a 200μL pipette tip on monolayer cells, followed by monitoring closure over 24 hours

  • Clone formation experiments: Assess long-term proliferative capacity following NDC1 modulation

• Invasion assays:

  • Transwell assay: Measures the ability of cells to invade through extracellular matrix

• Apoptosis detection:

  • Annexin V-FITC/PI flow cytometry: Quantifies early and late apoptotic cells

  • Western blotting for apoptosis markers (e.g., Caspase3, PTEN, TP53)

How does NDC1 contribute to cancer progression mechanisms?

NDC1 has emerged as a significant factor in multiple cancer types, with mechanistic studies revealing multiple pathways of influence:

Mechanistically, NDC1 knockdown experiments demonstrate:

• Enhanced E-cadherin expression (epithelial marker)

• Reduced Vimentin expression (mesenchymal marker)

• Indicating NDC1 likely promotes epithelial-mesenchymal transition in cancer cells

What is the role of Tmem48 mutation in mouse gametogenesis and development?

The skeletal fusions with sterility (sks) mouse model demonstrates a critical role for NDC1 in developmental processes:

• The autosomal recessive mutation in Tmem48 results in:

  • Male and female sterility due to defects in gametogenesis

  • Skeletal malformations

• Molecular basis:

  • The mutation causes aberrant splicing, specifically deleting exon 6 of the Tmem48 transcript

  • The defective protein disrupts nuclear pore complex function

• Experimental validation:

  • Complete phenotypic rescue was achieved through transgenesis of a genomic fragment containing wild-type Tmem48

  • Specific expression of TMEM48 was observed in germ cells of both males and females

This model provides compelling evidence that the nuclear pore complex plays an essential role in mammalian gametogenesis and skeletal development, with NDC1 serving as a key component in these processes .

How does NDC1 interact with other nuclear pore complex components?

NDC1 functions through specific interactions with other nuclear pore complex proteins:

• Nup53 interaction:

  • NDC1 binds directly to Nup53, which links the inner and outer rings of the NPC

  • This interaction connects to the central channel through Nup53's association with the Nup96/98 complex and Nup155

  • NDC1 and Nup53 function in parallel to drive nuclear assembly

• NUP155 interaction:

  • NUP155 and NDC1 interaction has been specifically implicated in NSCLC progression

  • This interaction represents a promising target for therapeutic intervention in cancer research

• Recruitment function:

  • NDC1 promotes the stable association of outer ring scaffold components in the nuclear envelope

  • It is recruited early to the nuclear rim and localizes to the ER and cytoplasmic puncta

  • This recruitment is essential for proper post-mitotic NPC assembly

What molecular pathways are regulated by NDC1 in normal and disease states?

NDC1 influences several key cellular pathways:

• Nuclear transport pathway:

  • NDC1 is essential for proper nuclear pore complex assembly

  • When NDC1 function is compromised, nuclear transport is delayed in post-mitotic cells

• Wnt/β-catenin signaling:

  • NDC1 has been demonstrated to advance cervical cancer progression via the Wnt/β-catenin pathway

  • This suggests a role beyond structural nuclear pore function

• Apoptotic regulation:

  • NDC1 suppression increases apoptosis-related gene expression (Caspase3, PTEN, TP53)

  • miR-421 inhibits NDC1 expression in NSCLC cells, thereby promoting apoptosis

• Cell adhesion and migration pathways:

  • NDC1 knockdown inhibits cell adhesion, migration, and invasion

  • NDC1 modulates epithelial-mesenchymal transition markers (E-cadherin and Vimentin)

How can NDC1 be targeted for potential therapeutic applications?

Based on current research, several targeting strategies show promise:

• Direct targeting approaches:

  • RNAi-based therapies (siRNA, shRNA) to reduce NDC1 expression

  • CRISPR-Cas9 gene editing to disrupt NDC1 function

  • Small molecule inhibitors targeting NDC1 protein interactions

• Indirect targeting mechanisms:

  • miRNA delivery (e.g., miR-421) to downregulate NDC1 expression

  • Targeting the Wnt/β-catenin pathway to counteract NDC1's oncogenic effects

  • Combination approaches with standard chemotherapies

• Biomarker applications:

  • NDC1 expression levels as prognostic indicators

  • Development of nomogram models incorporating NDC1 expression with other clinical features for cancer prognosis

For therapeutic applications, researchers have developed calibration curves and nomogram models based on NDC1 expression and clinical features to predict patient outcomes, demonstrating the translational potential of NDC1 research .

What experimental designs can help resolve contradictory findings about NDC1 function?

When confronting contradictory data about NDC1 function, researchers should consider:

• Tissue/cell type specificity:

  • Design experiments comparing NDC1 function across multiple cell types

  • Use tissue-specific knockout or knockdown approaches

  • Conduct weighted correlation network analysis (WGCNA) to identify co-expressed genes and their association with clinical traits

• Context-dependent function analysis:

  • Investigate NDC1 under various cellular stresses (e.g., serum starvation, hypoxia)

  • Assess function in the context of cell cycle phases

  • Examine NDC1's role during development versus homeostasis

• Comprehensive pathway analysis:

  • Perform GO and KEGG enrichment analysis on gene modules associated with NDC1

  • Use the "ClusterProfiler" R package to conduct functional annotation

  • Consider P < 0.05 or q < 0.05 as statistically significant thresholds for enrichment studies

• Rescue experiments:

  • Conduct complementation studies with wild-type versus mutant NDC1

  • Perform domain-specific rescue experiments to identify critical functional regions

  • Design experiments similar to the complete phenotypic rescue achieved in sks mice through wild-type Tmem48 transgenesis